subverts oxidative assault imposed by the host. 2 Moreover, macrophages play crucial role in body iron homoeostasis by recycling and redirecting it for erythropoiesis. 5 Therefore, cellular iron levels must be carefully regulated by Leishmania, because apart from being the precursor for iron-dependent enzymes and Fe-S cluster, iron also serves for free radical production as discussed above, to limit the availability of iron to pathogens. This involves the host mononuclear system, which chelates iron making it inaccessible to pathogens. In order to survive and replicate, Leishmania is equipped with iron-acquiring mechanisms 6 that harness iron sources from the macrophages. This suggested for the essence of iron for pathogenicity and survival of parasite, resulting in anaemia of chronic disease (ACD).
Lymphocytes also possess limited ability to sequester iron; T cells are more sensitive to changes in iron homoeostasis than B cells. 7 Reduction in iron availability interferes with lymphocyte proliferation, activation and cytokine production, thereby dampening the immune effector functions. The major iron acquisition routes in leucocytes are via. transferrin-mediated endocytosis by transferrin receptor, TfR, 8 iron bound to divalent metal transporter 1 (DMT1 or Nramp2) 9 and phagocytosis of senescent red blood cells while iron efflux is mediated solely by ferroportin (FPN), 10 which in turn is inversely regulated by the level of hepcidin (HPN) in infections and upon iron overload 11, 12 by inhibiting the antigen presentation and microbicidal activity in the form of hampered RNS production by iNOS. Also, the close interconnection between iron and immunity is governed by different cytokines which alter the cellular iron metabolism. 13 This tendency of host immune system to withhold iron from intracellular pathogens and limit their proliferation, in addition, to consolidation of its own immune effector pathways, this has been termed as nutritional immunity. Therefore, preventing the access of iron to pathogen is extremely important for immune cell functionality and homoeostasis.
Cellular stress by heme oxygenase-1 during Leishmania chagasi infection has also been shown to be responsible for inflammatory imbalance 14 the availability of iron to the pathogen. Apart from being the weapon of innate system, HPN has also been documented to be expressed on T cells, required for the activation and proliferation of these immune cells. 16 Despite of the proven role of iron homoeostasis, the concept of interconnection between iron and disease susceptibility still remains controversial in VL.
So far, there has been no evidence in any clinical set-up for the role of iron and its associated transporters in the VL pathogenesis. We aimed for prospective study of effect of VL-associated anaemia and iron homoeostasis on cellular immunity during VL, ultimately, determining pathogenicity of disease. Our findings document the role of iron acquisition machinery in VL cases as the key player in determining parasite-mediated immune modulations with direct effects on cytokine-mediated immune effector functions for its pathogenesis. Therefore, providing us the key to explore the iron homoeostasis pathways for therapeutic benefit and improving our understanding on host-pathogen interactions in infectious diseases.
| MATERIAL S AND ME THODS
We had performed the study on VL patients recruited to Kala-Azar and IFN-γ (Hs99999041_m1), and SYBR Green-based gene expression assays were performed for DMT1, FPN, HPN as described previously, 
| RE SULTS
Visceral leishmaniasis-associated anaemia also called as ACD has been a common manifestation of VL which resolves after therapy. Iron is essential building block of blood cells, and insufficient iron during ACD can perturb the iron homoeostasis. Considering 93 VL cases admitted for the study with anaemia and leucopenia ( Figure 1A) as the key manifestations, we sought to establish relationship between leucocyte count and haemoglobin levels in VL cases who were not receiving any antileishmanial treatment at the time of study. There was significant difference in the levels of haemoglobin in VL cases pre-(D-0) and thirty days post-treatment (D-Dis) suggesting for the disease associated anaemia during chronic infection ( Figure 1A ). Similarly, significantly high level of leucocyte count per microlitre blood was observed upon post-treatment ( Figure 1B ). This, indeed, raised concern to study correlation between two parameters during chronic Leishmania infection. We observed positive correlation between leucocyte count and haemoglobin levels (P = 0.0060 and r = 0.2991; Figure 1C ). This may indicate for the correlation between severities of symptoms;
however, no differences in the serum TIBC between the infected and healthy controls (EC; Figure 1D ) were observed. To further delineate the relationship between haemoglobin and immunity, the parasitespecific antibody titres and haemoglobin were determined. As shown Comparison between VL and EC was done using t test and between cell populations originating from the same donors using a paired t test. Non-parametric tests (Mann-Whitney U test or Wilcoxon matched pair test) were used when normality test failed. (ns, non-significant, **P < 0.01, ***P < 0.001)
in Figure 1E , statistically significant inverse correlation was found between the two parameters (P-value = 0.0042 and r = 0.6306), indi- IL-10, being immunoregulatory cytokine that regulates HPN homoeostasis, was elevated in PBMCs in pretreated as compared to post-treated cases (P-value < 0.0001) and healthy controls; splenic data supported the PBMCs data for pre-and post-treated subjects (P < 0.0001), with almost similar levels of transcripts in PBMCs and spleen ( Figure 4C ). The pathological consequences of the disease can be further supported by the inverse correlation between the IL-10 transcript and the haemoglobin levels ( Figure 5A ), which further added another dimension to establish the involvement of this anti-inflammatory cytokine in VL pathogenesis. Similarly, the regulatory effects of HPN were further identified in another correlation study where HPN expression was negatively correlated with the haemoglobin levels in active (pretreated) cases (Pearson's r = 0.6598, P = 0.004; Figure 5B ). Since, iron also serves as the catalyst for iNOS mediated NO production, direct correlation between the haemoglobin levels and the iNOS transcripts (Pearson's r = 0.5549, P = 0.0257; Figure 5C ) further consolidated the study regarding the role of iron in determining the immune responses against the intracellular parasite.
| D ISCUSS I ON
Major source of iron in human is found as heme moieties in haemoglobin. Iron deficiency/excess is associated with cellular and organ dysfunction. The causes underlying the ACD have been obscuring
and not much has been known; however, the increased uptake and retention of iron within cells reduces the functional iron required for production of haemoglobin. This in turn reduces the availability of oxygen to tissues leading to anaemia.
We took the advantage of availability of spleen aspirates from VL patients, containing parasitized macrophages to directly address
F I G U R E 3 Relative mRNA expression of major effector molecules in leucocytes of VL cases. mRNA expression of (A) HLA-DR in VL (pre-and post-treatment) and EC PBMC as well as splenocytes, and (B) comparative expression levels of iNOS in PBMCs and splenocytes.
Comparison between VL and EC was done using t test and between cell populations originating from the same donors using a paired t test. Non-parametric tests (Mann-Whitney U test or Wilcoxon matched pair test) were used when normality test failed. (ns = non-significant, **P < 0.01, ***P < 0.001). The gene transcripts associated with iron acquisition-DMT1 and TfR1, were unaltered during the course of VL but TfR1 was significantly higher in spleen at pretreatment than post-treatment which could be attributed to the essential role of this transporter in the spleen for iron regulation as previously reported. 28 However, the relative expression in PBMCs was higher than in the spleen; expression trend in PBMC was further reflected in the monocyte/macrophage population, in accordance with the reported study from Nairz et al.
29
There are reports from Legionella, justifying for the decreased levels of TfR1 in activated macrophages 30 which could be attributed to the presence of parasite and inflammatory environment mediated by IFN-γ. 31 The altered transcript levels of TfR1 during VL, but no Pearson's analysis was performed for the correlational study. Significant differences are indicated by P-values (*P < 0.05, **P < 0.01 and ***P < 0.001) Salmonella model 29 where a cascade of negative regulatory events were responsible for compromised effector functions as RNS formation and TNF-α production. 45 Similarly, iNOS, heme-containing effector molecule of innate immune armoury, expression was also compromised during infection, but no significant differences were observed in spleens of the VL cases (pre-and post-treatment), possibly due to residual infection in the spleen upon completion of treatment tenure; higher transcriptional levels in PBMCs of post-treated cases signified the improvement in haemoglobin levels upon cure, as a carrier of iron that serves as catalyst for NO production by directly influencing the iNOS levels, as reported previously. 3 However, no significant differences were observed in transcripts of iNOS in PBMCs and spleen, signifying the similar extent of compromised effector functions in spleen and PBMCs.
Correlation study further validated the relationship between the haemoglobin levels and iNOS transcripts strengthening the established studies which have suggested for the role of iron in innate antimicrobial defence in tissue culture and animal model. 
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